| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.60B | 37.47B | 33.71B | 30.47B | 27.45B | 27.39B |
| Gross Profit | 5.29B | 6.37B | 4.65B | 4.46B | 1.99B | 765.00M |
| EBITDA | 3.68B | 5.07B | 4.01B | 3.62B | 3.90B | 1.78B |
| Net Income | 1.48B | 1.16B | 1.38B | 656.00M | 943.00M | -1.05B |
Balance Sheet | ||||||
| Total Assets | 97.78B | 108.72B | 104.08B | 98.40B | 94.11B | 92.50B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 3.27B | 4.05B | 3.97B | 4.45B | 5.29B |
| Total Debt | 25.64B | 30.58B | 28.36B | 26.54B | 28.31B | 27.17B |
| Total Liabilities | 55.15B | 63.20B | 61.32B | 56.79B | 54.88B | 53.81B |
| Stockholders Equity | 41.56B | 44.37B | 41.72B | 40.65B | 38.36B | 37.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.38B | -2.27B | 1.61B | -3.95B | -4.87B |
| Operating Cash Flow | 0.00 | 1.71B | 5.08B | 5.53B | 449.00M | -1.12B |
| Investing Cash Flow | 0.00 | -4.31B | -5.57B | -3.65B | -2.15B | -3.56B |
| Financing Cash Flow | 0.00 | 1.78B | 604.00M | -2.36B | 894.00M | 4.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥13.72B | 7.48 | ― | 0.26% | 2.92% | 5.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥299.73B | 11.48 | ― | 1.61% | 1.51% | 14.49% | |
60 Neutral | ¥42.46B | 10.48 | ― | 2.17% | 4.27% | 33.45% | |
58 Neutral | ¥223.45B | 6.57 | 12.70% | 1.68% | 6.91% | 58.68% | |
54 Neutral | ¥19.10B | 12.97 | ― | 0.81% | 5.49% | 29.14% | |
50 Neutral | ¥18.67B | 16.20 | ― | 1.33% | 11.16% | -16.05% |